| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO | Chief Financial Officer
2 companies
Hirsch Andrew is a President &CEO at C4 Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2022 | CCCC C4 Therapeutics, Inc. | President &CEO | Buy | 10,000 | $8.40 | $84,000.00 | New | +8.3% | -64.4% |